Giapreza
Payments companies reported to CMS as associated with Giapreza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Giapreza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Giapreza
These are the largest totals companies reported as associated with Giapreza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Boldt | Los Angeles, CA | Anesthesiology | $104,536.82 |
| Louis Guzzi | Orlando, FL | Critical Care Medicine (Anesthesiology) | $71,216.74 |
| Rajkumar Dasgupta | Pasadena, CA | Pulmonary Disease | $49,947.53 |
| Jonathan Chow | Washington, DC | Critical Care Medicine (Anesthesiology) | $42,323.73 |
| Ara Klijian | Murrieta, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $39,536.22 |
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $28,552.59 |
| Samir Awad | Houston, TX | Surgical Critical Care | $26,179.04 |
| Timothy Misselbeck | Allentown, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $24,535.34 |
| Per Rosenkvist | Livingston, NJ | Acute Care (Nurse Practitioner) | $12,273.95 |
| Nishant Patel | Palm Beach Gardens, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $11,648.70 |
Prescribed Giapreza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.